Niero F - Search Results

1

HAART tolerability: post-exposure prophylaxis in healthcare workers versus treatment in HIV-infected patients.

Quirino T, Niero F, Ricci E, Pusterla L, Carradori S, Gabbuti A, Iemoli E, Landonio S, Faggion I, Bonfanti P; CISAI study group. Italian Coordination for the Study HIV Infection and Allergies. Quirino T, et al. Among authors: niero f. Antivir Ther. 2000 Sep;5(3):195-7. Antivir Ther. 2000. PMID: 11075939 Clinical Trial.

2

Short-term adverse effects from and discontinuation of antiretroviral post-exposure prophylaxis.

Puro V, De Carli G, Orchi N, Palvarini L, Chiodera A, Fantoni M, Del Borgo C, Iemoli E, Niero F, Monti M, Micheloni G, Caggese L, Lodesani C, Raineri G, Massari M, Drenaggi D, Ippolito G; Italian Registry of Antiretroviral Post-Exposure Prophylaxis. Puro V, et al. Among authors: niero f. J Biol Regul Homeost Agents. 2001 Jul-Sep;15(3):238-42. J Biol Regul Homeost Agents. 2001. PMID: 11693431

3

Successful Omalizumab treatment in HIV positive patient with chronic spontaneous urticaria: a case report.

Iemoli E, Niero F, Borgonovo L, Cossu MV, Piconi S. Iemoli E, et al. Among authors: niero f. Eur Ann Allergy Clin Immunol. 2017 Mar;49(2):88-91. Eur Ann Allergy Clin Immunol. 2017. PMID: 28294590 Free article.

4

Atherosclerosis is associated with multiple pathogenic mechanisms in HIV-infected antiretroviral-naive or treated individuals.

Piconi S, Parisotto S, Rizzardini G, Passerini S, Meraviglia P, Schiavini M, Niero F, Biasin M, Bonfanti P, Ricci ED, Trabattoni D, Clerici M. Piconi S, et al. Among authors: niero f. AIDS. 2013 Jan 28;27(3):381-9. doi: 10.1097/QAD.0b013e32835abcc9. AIDS. 2013. PMID: 23079800

5

Virological treatment failure of highly active antiretroviral therapy in an unselected cohort of HIV-infected patients.

Bonfanti P, Capetti A, Di Mattei P, Niero F, Rizzardini G. Bonfanti P, et al. Among authors: niero f. AIDS. 1998 Jun 18;12(9):1111. AIDS. 1998. PMID: 9662213 No abstract available.

6

Salvage therapy or simplification of salvage regimens with dolutegravir plus ritonavir-boosted darunavir dual therapy in highly cART-experienced subjects: an Italian cohort.

Capetti AF, Sterrantino G, Cossu MV, Cenderello G, Cattelan AM, De Socio GV, Rusconi S, Riccardi N, Baldin GM, Cima S, Niero FP, Rizzardini G, Sasset L. Capetti AF, et al. Among authors: niero fp. Antivir Ther. 2017;22(3):257-262. doi: 10.3851/IMP3095. Epub 2016 Sep 23. Antivir Ther. 2017. PMID: 27661787

7

Desensitization to trimethoprim-sulfamethoxazole in patients infected with human immunodeficiency virus.

Quirino T, Bonfanti P, Niero F, Rizzardini G, Iemoli E, Milazzo F. Quirino T, et al. Among authors: niero f. Clin Infect Dis. 1996 Feb;22(2):396. doi: 10.1093/clinids/22.2.396. Clin Infect Dis. 1996. PMID: 8838220 No abstract available.

8

A boceprevir failure in a patient infected with HCV genotype 1g: importance and limitations of virus genotyping prior to HCV protease-inhibitor-based therapy.

Cento V, Landonio S, De Luca F, Di Maio VC, Micheli V, Mirabelli C, Niero F, Magni C, Rizzardini G, Perno CF, Ceccherini-Silberstein F. Cento V, et al. Among authors: niero f. Antivir Ther. 2013;18(4):645-8. doi: 10.3851/IMP2529. Epub 2013 Feb 15. Antivir Ther. 2013. PMID: 23411358

9

Strategic use of dual regimens of boosted protease inhibitors plus maraviroc in poorly adherent subjects in view of long-acting drugs: A retrospective study.

Capetti AF, Micale M, Carenzi L, Niero F, Landonio S, Vimercati S, Dedivitiis G, Rizzardini G. Capetti AF, et al. Among authors: niero f. Medicine (Baltimore). 2017 Feb;96(7):e5728. doi: 10.1097/MD.0000000000005728. Medicine (Baltimore). 2017. PMID: 28207500 Free PMC article.

10

Are direct-acting antivirals safe and effective in hepatitis C virus-cryoglobulinemia? virological, immunological, and clinical data from a real-life experience.

Passerini M, Schiavini M, Magni CF, Landonio S, Niero F, Passerini S, Croci AL, Bolis M, Scalzi V, Gubertini G, Ricci ED, Galli M, Rizzardini G. Passerini M, et al. Among authors: niero f. Eur J Gastroenterol Hepatol. 2018 Oct;30(10):1208-1215. doi: 10.1097/MEG.0000000000001239. Eur J Gastroenterol Hepatol. 2018. PMID: 30138160

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters